{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:41:59Z","timestamp":1791405719796,"version":"4.3.3"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jaip.2026.02.021","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T20:09:16Z","timestamp":1772309356000},"page":"1329-1341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Respiratory Biologics Utilization, Prescription Predictors, and Outcomes in Patients With Asthma and Comorbid Overweight or Obesity"],"prefix":"10.1016","volume":"14","author":[{"given":"Dinah","family":"Foer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane L.","family":"Seger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Fiskio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayma","family":"Alzaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayobami","family":"Akenroye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.02.021_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12931-018-0742-y","article-title":"Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis","volume":"19","author":"Bloechliger","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2026.02.021_bib2","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1080\/02770903.2018.1539100","article-title":"A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma","volume":"56","author":"Al Efraij","year":"2019","journal-title":"J Asthma"},{"key":"10.1016\/j.jaip.2026.02.021_bib3","article-title":"Inhaled corticoids in asthmatic patients: effect on body mass index and spirometry","volume":"141","author":"Dos Reis Pacheco","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.021_bib4","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/all.13874","article-title":"Oral corticosteroid use, morbidity and mortality in asthma: a nationwide prospective cohort study in Sweden","volume":"74","author":"Ekstrom","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2026.02.021_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2017.04.009","article-title":"Oral corticosteroid exposure and adverse effects in asthmatic patients","volume":"141","author":"Sullivan","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.021_bib6","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jaip.2020.06.019","article-title":"Oral corticosteroid treatment patterns of patients in the United States with persistent asthma","volume":"9","author":"Tran","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.021_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1164\/rccm.202402-0368OC","article-title":"Association of dose of inhaled corticosteroids and frequency of adverse events","volume":"211","author":"Bloom","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1183\/09031936.06.00077205","article-title":"Influence of body mass index on the response to asthma controller agents","volume":"27","author":"Peters-Golden","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2026.02.021_bib9","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jaci.2010.12.010","article-title":"Decreased response to inhaled steroids in overweight and obese asthmatic children","volume":"127","author":"Forno","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.021_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3109\/02770900903338494","article-title":"Body mass index and response to asthma therapy: fluticasone propionate\/salmeterol versus montelukast","volume":"47","author":"Camargo","year":"2010","journal-title":"J Asthma"},{"key":"10.1016\/j.jaip.2026.02.021_bib11","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.rmed.2007.06.031","article-title":"Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma","volume":"101","author":"Boulet","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib12","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib13","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jaip.2019.09.036","article-title":"Efficacy of intravenous reslizumab in oral corticosteroid\u2013dependent asthma","volume":"8","author":"Nair","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.021_bib15","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1056\/NEJMoa1703501","article-title":"Oral glucocorticoid\u2013sparing effect of benralizumab in severe asthma","volume":"376","author":"Nair","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s41030-022-00211-x","article-title":"Utility of hypoglycemic agents to treat asthma with comorbid obesity","volume":"9","author":"Ge","year":"2022","journal-title":"Pulm Ther"},{"key":"10.1016\/j.jaip.2026.02.021_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/ACI.0000000000001045","article-title":"The role of type 2 diabetes in the severity of adult asthma","volume":"25","author":"Pham","year":"2025","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.021_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaci.2018.02.004","article-title":"Obesity and asthma","volume":"141","author":"Peters","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.021_bib20","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib21","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1164\/rccm.202406-1166SO","article-title":"Obesity-related asthma: a pathobiology-based overview of existing and emerging treatment approaches","volume":"210","author":"Althoff","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib22","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1304048","article-title":"Dupilumab in persistent asthma with elevated eosinophil levels","volume":"368","author":"Wenzel","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib23","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1016\/j.jaip.2025.07.041","article-title":"Effects of obesity on response to asthma biologic treatment: longitudinal data from the United Kingdom Severe Asthma Registry","volume":"13","author":"Gonem","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.021_bib24","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2023.01.020","article-title":"Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: a target trial emulation","volume":"151","author":"Akenroye","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.021_bib25","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jaip.2023.03.003","article-title":"Factors associated with asthma biologic prescribing and primary adherence among adults in a large health system","volume":"11","author":"Gleeson","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.021_bib26","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaip.2019.08.024","article-title":"Trends and disparities in asthma biologic use in the United States","volume":"8","author":"Inselman","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.021_bib27","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1016\/j.jaip.2021.01.039","article-title":"Lower use of biologics for the treatment of asthma in publicly insured individuals","volume":"9","author":"Akenroye","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.021_bib28","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jaci.2017.04.047","article-title":"Obesity\u2019s effect on asthma extends to diagnostic criteria","volume":"141","author":"Lugogo","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.021_bib29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jaip.2026.02.021_bib31","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.jaci.2011.03.036","article-title":"Obesity and asthma: an association modified by age of asthma onset","volume":"127","author":"Holguin","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.02.021_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/thx.2007.082784","article-title":"Body mass index and asthma severity in the National Asthma Survey","volume":"63","author":"Taylor","year":"2008","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2026.02.021_bib33","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jaip.2023.12.041","article-title":"Weight loss interventions for adults with obesity-related asthma","volume":"12","author":"Foer","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.021_bib34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/jamia\/ocx071","article-title":"Biases introduced by filtering electronic health records for patients with \u201ccomplete data.\u201d","volume":"24","author":"Weber","year":"2017","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.jaip.2026.02.021_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1164\/rccm.201611-2232PP","article-title":"Eosinophilic and noneosinophilic Asthma","volume":"197","author":"Carr","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib36","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. state-level prevalence of adult obesity and severe obesity","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaip.2019.08.023","article-title":"Underrepresentation of blacks, smokers, and obese patients in studies of monoclonal antibodies for asthma","volume":"8","author":"Akenroye","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.021_bib38","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.201808-1543OC","article-title":"Multiview cluster analysis identifies variable corticosteroid response phenotypes in severe asthma","volume":"199","author":"Wu","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib39","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1378\/chest.12-0872","article-title":"Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient Cohort according to BMI","volume":"143","author":"Gibeon","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2026.02.021_bib40","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1016\/j.jaip.2021.02.059","article-title":"Cluster analysis of inflammatory biomarker expression in the International Severe Asthma Registry","volume":"9","author":"Denton","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.021_bib41","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1016\/j.jaip.2023.06.049","article-title":"Characterization of obesity in severe asthma in the German Asthma Net","volume":"11","author":"Bal","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.02.021_bib42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.anai.2022.01.025","article-title":"Impact of body mass index on omalizumab response in adults with moderate-to-severe allergic asthma","volume":"128","author":"Geng","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.02.021_bib43","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12931-019-1134-7","article-title":"Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight\/body mass index: meta-analysis of MENSA and MUSCA","volume":"20","author":"Albers","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2026.02.021_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(17)30344-2","article-title":"Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies","volume":"6","author":"FitzGerald","year":"2018","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.anai.2021.05.021","article-title":"Real-world effectiveness of mepolizumab in patients with severe asthma and associated comorbidities","volume":"127","author":"Casale","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.02.021_bib46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejim.2018.01.026","article-title":"Factors reducing omalizumab response in severe asthma","volume":"52","author":"Sposato","year":"2018","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib47","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pupt.2014.09.007","article-title":"Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy","volume":"31","author":"Novelli","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.jaip.2026.02.021_bib48","article-title":"Predictors of a minimal clinically important difference following omalizumab treatment in adult patients with severe allergic asthma","volume":"8","author":"Huang","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2026.02.021_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106938","article-title":"Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline","volume":"202","author":"Bourdin","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2026.02.021_bib50","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1503\/cmaj.081332","article-title":"Overdiagnosis of asthma in obese and nonobese adults","volume":"179","author":"Aaron","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.jaip.2026.02.021_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982600173X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982600173X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:26:39Z","timestamp":1781825199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321982600173X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S221321982600173X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.02.021","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Respiratory Biologics Utilization, Prescription Predictors, and Outcomes in Patients With Asthma and Comorbid Overweight or Obesity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.02.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}